121 related articles for article (PubMed ID: 36924894)
21. TME-Responsive Polyprodrug Micelles for Multistage Delivery of Doxorubicin with Improved Cancer Therapeutic Efficacy in Rodents.
Zhang S; Zhu P; He J; Dong S; Li P; Zhang CY; Ma T
Adv Healthc Mater; 2020 Sep; 9(18):e2000387. PubMed ID: 32815646
[TBL] [Abstract][Full Text] [Related]
22. Facile Fabrication of 10-Hydroxycamptothecin-Backboned Amphiphilic Polyprodrug with Precisely Tailored Drug Loading Content for Controlled Release.
Zhang X; Zhang M; Wang M; Peng H; Hua Q; Ma L; Wang B; Wei H
Bioconjug Chem; 2018 Jul; 29(7):2239-2247. PubMed ID: 29847101
[TBL] [Abstract][Full Text] [Related]
23. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-responsive block copolymer polyprodrugs for complementary photodynamic-chemotherapy.
Zhou Q; Mohammed F; Wang Y; Wang J; Lu N; Li J; Ge Z
J Control Release; 2021 Nov; 339():130-142. PubMed ID: 34560158
[TBL] [Abstract][Full Text] [Related]
25. Dual-Responsive Polyprodrug Nanoparticles with Cascade-Enhanced Magnetic Resonance Signals for Deep-Penetration Drug Release in Tumor Therapy.
Hao Q; Wang Z; Zhao W; Wen L; Wang W; Lu S; Xing D; Zhan M; Hu X
ACS Appl Mater Interfaces; 2020 Nov; 12(44):49489-49501. PubMed ID: 33079514
[TBL] [Abstract][Full Text] [Related]
26. Tirapazamine-embedded polyplatinum(iv) complex: a prodrug combo for hypoxia-activated synergistic chemotherapy.
Guo D; Xu S; Yasen W; Zhang C; Shen J; Huang Y; Chen D; Zhu X
Biomater Sci; 2020 Jan; 8(2):694-701. PubMed ID: 31777870
[TBL] [Abstract][Full Text] [Related]
27. Redox-responsive self-assembled polymeric nanoprodrug for delivery of gemcitabine in B-cell lymphoma therapy.
Zhong W; Zhang X; Duan X; Liu H; Fang Y; Luo M; Fang Z; Miao C; Lin D; Wu J
Acta Biomater; 2022 May; 144():67-80. PubMed ID: 35331940
[TBL] [Abstract][Full Text] [Related]
28. One-Pot Synthesis of pH/Redox Responsive Polymeric Prodrug and Fabrication of Shell Cross-Linked Prodrug Micelles for Antitumor Drug Transportation.
Li L; Li D; Zhang M; He J; Liu J; Ni P
Bioconjug Chem; 2018 Aug; 29(8):2806-2817. PubMed ID: 30005157
[TBL] [Abstract][Full Text] [Related]
29. PEGylated Poly-HDACi: A Designer Polyprodrug from Optimized Drug Units.
Han J; Wang DY; Wang Q; Meng L; Luo Z; Li J; Kang Y; Lv W; Huang Q; Wang PG; Wang Y; Shen J; Wang Y
Chemistry; 2022 Jan; 28(4):e202103114. PubMed ID: 34820923
[TBL] [Abstract][Full Text] [Related]
30. Enhanced Tumor Penetration and Chemotherapy Efficiency by Covalent Self-Assembled Nanomicelle Responsive to Tumor Microenvironment.
Ma X; Bai S; Zhang X; Ma X; Jia D; Shi X; Shao J; Xue P; Kang Y; Xu Z
Biomacromolecules; 2019 Jul; 20(7):2637-2648. PubMed ID: 31141665
[TBL] [Abstract][Full Text] [Related]
31. Self-immolative polyprodrug-based tumor-specific cascade amplificated drug release nanosystem for orchestrated synergistic cancer therapy.
Wang K; Xiao X; Liu Y; Zong Q; Tu Y; Yuan Y
Biomaterials; 2022 Oct; 289():121803. PubMed ID: 36150300
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
[TBL] [Abstract][Full Text] [Related]
33. A multifunctional platinum(IV) and cyanine dye-based polyprodrug for trimodal imaging-guided chemo-phototherapy.
Li S; Wu Y; Liu S; Wu T; Liu G; Li T; Chen Z
J Mater Chem B; 2022 Feb; 10(7):1031-1041. PubMed ID: 35080231
[TBL] [Abstract][Full Text] [Related]
34. A General Strategy for Macrotheranostic Prodrug Activation: Synergy between the Acidic Tumor Microenvironment and Bioorthogonal Chemistry.
Dong Y; Tu Y; Wang K; Xu C; Yuan Y; Wang J
Angew Chem Int Ed Engl; 2020 Apr; 59(18):7168-7172. PubMed ID: 32003112
[TBL] [Abstract][Full Text] [Related]
35. pH/ROS dual-responsive supramolecular polypeptide prodrug nanomedicine based on host-guest recognition for cancer therapy.
Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Chen T; Dong CM; Yao Y
Acta Biomater; 2022 Apr; 143():381-391. PubMed ID: 35272024
[TBL] [Abstract][Full Text] [Related]
36. Design, postpolymerization conjugation and self-assembly of a di-block copolymer-based prodrug for tumor intracellular acid-triggered DOX release.
Dong Y; Du P; Pei M; Liu P
J Mater Chem B; 2019 Sep; 7(37):5640-5647. PubMed ID: 31465071
[TBL] [Abstract][Full Text] [Related]
37. Synergistic action of doxorubicin and 7-Ethyl-10-hydroxycamptothecin polyphosphorylcholine polymer prodrug.
Wu Z; Li S; Cai Y; Chen F; Chen Y; Luo X
Colloids Surf B Biointerfaces; 2020 May; 189():110741. PubMed ID: 32032928
[TBL] [Abstract][Full Text] [Related]
38. Reactive oxygen species-responsive polyprodrug micelles deliver cell cycle regulators for chemosensitization.
Sun Y; Wu Q; Fu Q; Cong H; Shen Y; Yu B; Hu H
Talanta; 2024 Jan; 267():125242. PubMed ID: 37801926
[TBL] [Abstract][Full Text] [Related]
39. Tumor-Microenvironment-Activatable Nanoreactor Based on a Polyprodrug for Multimodal-Imaging-Medicated Enhanced Cancer Chemo/Phototherapy.
Shi X; Ma X; Ren E; Zhang Y; Jia D; Gao Y; Xue P; Kang Y; Liu G; Xu Z
ACS Appl Mater Interfaces; 2019 Oct; 11(43):40704-40715. PubMed ID: 31577408
[TBL] [Abstract][Full Text] [Related]
40. Light-Activatable Prodrug and AIEgen Copolymer Nanoparticle for Dual-Drug Monitoring and Combination Therapy.
Wu P; Wang X; Wang Z; Ma W; Guo J; Chen J; Yu Z; Li J; Zhou D
ACS Appl Mater Interfaces; 2019 May; 11(20):18691-18700. PubMed ID: 31038909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
